
Salveen Richter
Stock Analyst at Goldman Sachs
(4.62)
# 938
Out of 5,162 analysts
574
Total ratings
48.9%
Success rate
11.1%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SMMT Summit Therapeutics | Maintained: Buy | $43 | $15.08 | +185.24% | 10 | Nov 16, 2026 | |
| IMNM Immunome | Maintained: Buy | $37 | $18.70 | +97.86% | 5 | Nov 16, 2026 | |
| FDMT 4D Molecular Therapeutics | Maintained: Buy | $33 → $32 | $12.12 | +164.14% | 14 | Nov 13, 2026 | |
| BRVE Braveheart Bio | Reiterated: Buy | $48 → $49 | $20.50 | +139.02% | 3 | Nov 11, 2026 | |
| IONS Ionis Pharmaceuticals | Rated: Hold | $56 → $41 | $27.31 | +50.13% | 21 | Nov 9, 2026 | |
| MRNA Moderna | Reiterated: Hold | $137 → $195 | $231.35 | -15.71% | 51 | Nov 8, 2026 | |
| AMGN Amgen | Reiterated: Buy | $481 → $536 | $467.06 | +14.76% | 25 | Nov 4, 2026 | |
| TLV: TEVA Teva Pharmaceutical Industries Limited | Reiterated: Buy | ILA 15,874 → ILA 17,462 | ILA 13,970 | +24.99% | 2 | Nov 4, 2026 | |
| RARE Ultragenyx Pharmaceutical | Reiterated: Hold | $19 → $17 | $16.27 | +4.49% | 16 | Nov 4, 2026 | |
| VRTX Vertex Pharmaceuticals | Rated: Buy | $654 → $725 | $542.62 | +33.61% | 32 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $550 → $320 | $156.65 | +104.28% | 23 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $142 → $155 | $167.95 | -7.71% | 18 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 → $68 | $25.85 | +163.06% | 6 | Oct 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $20.67 | -3.24% | 4 | Oct 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $972 | $951.19 | +2.19% | 26 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $46 → $31 | $24.63 | +25.86% | 24 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $73 | $12.93 | +464.58% | 1 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $69 → $70 | $56.70 | +23.46% | 18 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $4.21 | +208.79% | 7 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $48 → $55 | $42.62 | +29.05% | 17 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 | $3.97 | +76.32% | 2 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $9 | $10.55 | -14.69% | 18 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $67 → $80 | $48.31 | +65.60% | 7 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $110 → $118 | $121.70 | -3.04% | 27 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32 | $31.76 | +0.76% | 17 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $31 | $18.08 | +71.46% | 12 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $250 | $250.48 | -0.19% | 31 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 | $22.94 | +78.73% | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $26 | $12.57 | +106.84% | 2 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 → $17 | $16.01 | +6.18% | 23 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 | $17.77 | n/a | 6 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $15 → $17 | $18.14 | n/a | 11 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 | $10.90 | n/a | 1 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 → $40 | $18.89 | n/a | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.93 | n/a | 9 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $39 | $2.39 | n/a | 1 | Apr 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 → $30 | $9.54 | n/a | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $48 → $5 | $29.48 | n/a | 8 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $78.17 | n/a | 1 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $62.32 | n/a | 1 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 | $68.97 | n/a | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $7 | $2.14 | n/a | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $31 | $0.827 | n/a | 10 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $225 | $259.48 | n/a | 2 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $22 | $3.89 | n/a | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 → $7 | $15.64 | n/a | 2 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 → $1 | $8.04 | n/a | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $9 | $3.33 | n/a | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $34 → $6 | $2.01 | n/a | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $28 → $30 | $4.01 | n/a | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $126 → $131 | $425.21 | n/a | 7 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $11 | $1.33 | n/a | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 | $4.16 | n/a | 1 | Oct 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $45 → $47 | $47.15 | n/a | 2 | May 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $4 → $2 | $7.00 | n/a | 3 | Nov 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $44 → $76 | $593.31 | n/a | 3 | Oct 29, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $18 → $2 | $1.99 | n/a | 2 | Oct 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $0.0001 | n/a | 1 | Dec 2, 2011 |
Summit Therapeutics
Nov 16, 2026
Maintained: Buy
Price Target: $43
Current: $15.08
Upside: +185.24%
Immunome
Nov 16, 2026
Maintained: Buy
Price Target: $37
Current: $18.70
Upside: +97.86%
4D Molecular Therapeutics
Nov 13, 2026
Maintained: Buy
Price Target: $33 → $32
Current: $12.12
Upside: +164.14%
Braveheart Bio
Nov 11, 2026
Reiterated: Buy
Price Target: $48 → $49
Current: $20.50
Upside: +139.02%
Ionis Pharmaceuticals
Nov 9, 2026
Rated: Hold
Price Target: $56 → $41
Current: $27.31
Upside: +50.13%
Moderna
Nov 8, 2026
Reiterated: Hold
Price Target: $137 → $195
Current: $231.35
Upside: -15.71%
Amgen
Nov 4, 2026
Reiterated: Buy
Price Target: $481 → $536
Current: $467.06
Upside: +14.76%
Teva Pharmaceutical Industries Limited
Nov 4, 2026
Reiterated: Buy
Price Target: ILA 15,874 → ILA 17,462
Current: ILA 13,970
Upside: +24.99%
Ultragenyx Pharmaceutical
Nov 4, 2026
Reiterated: Hold
Price Target: $19 → $17
Current: $16.27
Upside: +4.49%
Vertex Pharmaceuticals
Nov 3, 2026
Rated: Buy
Price Target: $654 → $725
Current: $542.62
Upside: +33.61%
Oct 30, 2026
Reiterated: Buy
Price Target: $550 → $320
Current: $156.65
Upside: +104.28%
Oct 29, 2026
Reiterated: Hold
Price Target: $142 → $155
Current: $167.95
Upside: -7.71%
Oct 21, 2026
Reiterated: Buy
Price Target: $62 → $68
Current: $25.85
Upside: +163.06%
Oct 8, 2026
Reiterated: Hold
Price Target: $20
Current: $20.67
Upside: -3.24%
Oct 1, 2026
Reiterated: Buy
Price Target: $972
Current: $951.19
Upside: +2.19%
Sep 30, 2026
Rated: Hold
Price Target: $46 → $31
Current: $24.63
Upside: +25.86%
Sep 1, 2026
Reiterated: Buy
Price Target: $73
Current: $12.93
Upside: +464.58%
Aug 31, 2026
Reiterated: Hold
Price Target: $69 → $70
Current: $56.70
Upside: +23.46%
Aug 11, 2026
Reiterated: Buy
Price Target: $13
Current: $4.21
Upside: +208.79%
Aug 10, 2026
Rated: Hold
Price Target: $48 → $55
Current: $42.62
Upside: +29.05%
Aug 6, 2026
Reiterated: Hold
Price Target: $7
Current: $3.97
Upside: +76.32%
Aug 6, 2026
Reiterated: Sell
Price Target: $9
Current: $10.55
Upside: -14.69%
Aug 5, 2026
Rated: Buy
Price Target: $67 → $80
Current: $48.31
Upside: +65.60%
Jul 29, 2026
Reiterated: Hold
Price Target: $110 → $118
Current: $121.70
Upside: -3.04%
Jul 21, 2026
Reiterated: Hold
Price Target: $32
Current: $31.76
Upside: +0.76%
Jul 20, 2026
Reiterated: Buy
Price Target: $22 → $31
Current: $18.08
Upside: +71.46%
Jul 13, 2026
Reiterated: Buy
Price Target: $250
Current: $250.48
Upside: -0.19%
Jun 1, 2026
Reiterated: Buy
Price Target: $41
Current: $22.94
Upside: +78.73%
Apr 9, 2026
Reiterated: Buy
Price Target: $14 → $26
Current: $12.57
Upside: +106.84%
Feb 25, 2026
Reiterated: Hold
Price Target: $19 → $17
Current: $16.01
Upside: +6.18%
Oct 30, 2025
Reiterated: Hold
Price Target: $16
Current: $17.77
Upside: n/a
Aug 7, 2025
Reiterated: Sell
Price Target: $15 → $17
Current: $18.14
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $19
Current: $10.90
Upside: n/a
Jan 28, 2025
Reiterated: Buy
Price Target: $46 → $40
Current: $18.89
Upside: n/a
Dec 19, 2024
Rated: Hold
Price Target: n/a
Current: $7.93
Upside: n/a
Apr 2, 2024
Initiated Coverage: Hold
Price Target: $39
Current: $2.39
Upside: n/a
Mar 5, 2024
Reiterated: Buy
Price Target: $37 → $30
Current: $9.54
Upside: n/a
Feb 16, 2024
Reiterated: Hold
Price Target: $48 → $5
Current: $29.48
Upside: n/a
Jan 8, 2024
Reiterated: Buy
Price Target: n/a
Current: $78.17
Upside: n/a
Jan 5, 2024
Reiterated: Buy
Price Target: n/a
Current: $62.32
Upside: n/a
Jul 31, 2023
Reiterated: Buy
Price Target: $53
Current: $68.97
Upside: n/a
Jun 12, 2023
Reiterated: Sell
Price Target: $7
Current: $2.14
Upside: n/a
Mar 1, 2023
Reiterated: Buy
Price Target: $32 → $31
Current: $0.827
Upside: n/a
Feb 24, 2023
Reiterated: Buy
Price Target: $225
Current: $259.48
Upside: n/a
Nov 14, 2022
Initiated Coverage: Hold
Price Target: $22
Current: $3.89
Upside: n/a
Nov 11, 2022
Downgraded: Hold
Price Target: $30 → $7
Current: $15.64
Upside: n/a
Nov 10, 2022
Reiterated: Hold
Price Target: $2 → $1
Current: $8.04
Upside: n/a
Nov 9, 2022
Reiterated: Hold
Price Target: $8 → $9
Current: $3.33
Upside: n/a
Nov 3, 2022
Reiterated: Hold
Price Target: $34 → $6
Current: $2.01
Upside: n/a
Mar 4, 2021
Upgraded: Buy
Price Target: $28 → $30
Current: $4.01
Upside: n/a
Mar 1, 2021
Reiterated: Hold
Price Target: $126 → $131
Current: $425.21
Upside: n/a
Nov 9, 2020
Reiterated: Sell
Price Target: $11
Current: $1.33
Upside: n/a
Oct 28, 2020
Downgraded: Hold
Price Target: $40
Current: $4.16
Upside: n/a
May 8, 2020
Reiterated: Hold
Price Target: $45 → $47
Current: $47.15
Upside: n/a
Nov 13, 2019
Reiterated: Sell
Price Target: $4 → $2
Current: $7.00
Upside: n/a
Oct 29, 2013
Rated: Hold
Price Target: $44 → $76
Current: $593.31
Upside: n/a
Oct 15, 2013
Downgraded: Hold
Price Target: $18 → $2
Current: $1.99
Upside: n/a
Dec 2, 2011
Initiated Coverage: Buy
Price Target: $13
Current: $0.0001
Upside: n/a